Arrowstreet Capital’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8M Sell
153,049
-82,444
-35% -$23.5M 0.03% 493
2026
Q1
$40.8M Buy
235,493
+49,578
+27% +$10.2M 0.02% 548
2025
Q4
$47.6M Sell
185,915
-115,228
-38% -$30.2M 0.03% 497
2025
Q3
$78.3M Buy
301,143
+176,322
+141% +$46.4M 0.05% 345
2025
Q2
$30.5M Buy
124,821
+121,678
+3,871% +$30.3M 0.02% 557
2025
Q1
$832K Buy
+3,143
New +$850K ﹤0.01% 1512
2024
Q4
Sell
-274,821
Closed -$87M 1852
2024
Q3
$87M Sell
274,821
-111,640
-29% -$39.7M 0.07% 229
2024
Q2
$144M Sell
386,461
-401,489
-51% -$136M 0.13% 140
2024
Q1
$273M Buy
787,950
+151,034
+24% +$57.2M 0.25% 85
2023
Q4
$292M Buy
636,916
+72,131
+13% +$35.6M 0.31% 73
2023
Q3
$275M Buy
564,785
+422,123
+296% +$198M 0.33% 69
2023
Q2
$63.8M Buy
142,662
+109,033
+324% +$54.9M 0.08% 210
2023
Q1
$16.3M Sell
33,629
-87,516
-72% -$43.3M 0.02% 445
2022
Q4
$62M Buy
121,145
+45,146
+59% +$23.7M 0.09% 210
2022
Q3
$36.9M Buy
75,999
+75,303
+10,819% +$36.6M 0.05% 274
2022
Q2
$326K Sell
696
-348,055
-100% -$155M ﹤0.01% 1116
2022
Q1
$152M Buy
+348,751
New +$146M 0.19% 134
2021
Q4
Sell
-2,800
Closed -$1.09M 1562
2021
Q3
$1.09M Buy
+2,800
New +$1.19M ﹤0.01% 1276
2021
Q1
Sell
-7,607
Closed -$3.12M 2360
2020
Q4
$3.12M Buy
+7,607
New +$3.16M ﹤0.01% 1416
2020
Q3
Sell
-1,225
Closed -$475K 2404
2020
Q2
$475K Sell
1,225
-192,449
-99% -$72M ﹤0.01% 1978
2020
Q1
$60.8M Buy
+193,674
New +$65.3M 0.17% 117
2019
Q2
Sell
-244,636
Closed -$65.1M 1517
2019
Q1
$65.1M Sell
244,636
-35,949
-13% -$10.4M 0.15% 155
2018
Q4
$80.4M Buy
280,585
+136,350
+95% +$43.2M 0.21% 115
2018
Q3
$48.8M Buy
144,235
+85,230
+144% +$27.7M 0.11% 189
2018
Q2
$17.6M Buy
59,005
+57,405
+3,588% +$16.8M 0.04% 322
2018
Q1
$430K Sell
1,600
-149,572
-99% -$40.5M ﹤0.01% 975
2017
Q4
$37.5M Buy
151,172
+33,100
+28% +$8.17M 0.09% 216
2017
Q3
$28.8M Buy
118,072
+75,172
+175% +$18.4M 0.08% 230
2017
Q2
$10.3M Buy
+42,900
New +$9.71M 0.03% 354
2016
Q3
Sell
-27,559
Closed -$4.96M 1545
2016
Q2
$4.96M Buy
27,559
+5,159
+23% +$916K 0.02% 591
2016
Q1
$4.1M Sell
22,400
-6,136
-22% -$1.06M 0.02% 597
2015
Q4
$5.09M Sell
28,536
-40,364
-59% -$7.08M 0.02% 532
2015
Q3
$12.3M Buy
68,900
+53,900
+359% +$9.96M 0.06% 287
2015
Q2
$2.87M Buy
+15,000
New +$2.78M 0.02% 554
2015
Q1
Sell
-307,445
Closed -$44.2M 1099
2014
Q4
$44.2M Sell
307,445
-105,031
-25% -$14.3M 0.25% 89
2014
Q3
$53.7M Buy
412,476
+254,503
+161% +$32.3M 0.29% 94
2014
Q2
$20.2M Buy
+157,973
New +$18.7M 0.1% 197
2014
Q1
Sell
-15,490
Closed -$1.6M 1223
2013
Q4
$1.6M Buy
+15,490
New +$1.52M 0.01% 717

Other funds holding HUM

Arrowstreet Capital's HUM Position: Q2 2026 in Review

Arrowstreet Capital reduced its Humana (HUM) stake by 35% in Q2 2026, selling an estimated $23.5M and leaving 153,049 shares worth $60.8M. The position accounts for 0.03% of the portfolio, ranked #493.

Arrowstreet Capital first reported a position in HUM in Q4 2013 and has held it in 38 quarters since. The position peaked at $292M in Q4 2023. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Arrowstreet Capital held 153,049 shares of Humana worth $60.8M as of Q2 2026.
  • Arrowstreet Capital sold 82,444 Humana shares in Q2 2026, an estimated $23.5M.
  • Humana made up 0.03% of Arrowstreet Capital's portfolio in Q2 2026, its #493 holding.
  • Arrowstreet Capital first reported a position in Humana in Q4 2013 and has held it in 38 quarters since.
  • Arrowstreet Capital's Humana position peaked at $292M in Q4 2023.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.